ReShape Lifesciences looks to cut monthly expenses by 25%

ReShape Lifesciences (NSDQ:RSLS) said on Tuesday it plans to cut operating expenses by roughly 25%

The San Clemente, Calif.-based company said the cut will reduce its monthly cash burn to $1.8 million, down from earlier guidance which expected expenditures of $2.5 million per month.

ReShape Lifesciences said it is also reviewing its ReShape product line and cost structure as it continues with integration of ReShape Medical, which it acquired last October under its previous brand, EnteroMedics, and BarioSurg, which it acquired last May.

ReShape Lifesciences rebranded from its former EnteroMedics moniker last October, saying the new name reflects the company’s growth to providing a number of medical devices related to caring for and treating obesity and its associated health conditions.

The post ReShape Lifesciences looks to cut monthly expenses by 25% appeared first on MassDevice.

from MassDevice http://ift.tt/2u8vCvL